The Realities of Cannabis Medication: Dr. Jacqueline Bainbridge's Journey
Episode Overview
Dr. Bainbridge sheds light on the complexities of cannabis medication research and the challenges of FDA approval for new drugs The episode highlights the critical lessons learned from the rejection of Rimonabant by the FDA, emphasizing the importance of FDA review in saving lives Dr. Bainbridge discusses the impact of cannabis legalization on patient honesty with practitioners, emphasizing the need for transparency and understanding of product compositions The conversation delves into the intricacies of conducting clinical research on cannabinoids and the impact of legalization on patient honesty with practitioners Dr. Bainbridge provides valuable insights into the limitations and complexities of cannabis research, emphasizing the need for transparency and understanding of product compositions
I wish it was a little bit easier, a little less red tape, but I understand it. The universities get federal funding and so you can't compromise other federal funding for using a scheduled on-product.
What does it take to turn cannabis into a legitimate medication? In this episode of 'High Truths on Drugs and Addiction', Dr. Roneet Lev sits down with Dr. Jacqueline Bainbridge, a seasoned expert in cannabinoid research from the University of Colorado Anschutz Medical Campus. Dr. Bainbridge brings her wealth of knowledge to the table, discussing the hurdles and triumphs in the world of cannabis medication research.
She sheds light on the painstaking process of getting FDA approval for new drugs, sharing stories from her work on clinical trials for conditions like back pain, Parkinson’s disease, and autism. Ever wondered why some cannabis-based treatments make it to the market while others don’t? Dr. Bainbridge explains the rigorous standards and critical reviews that ensure only safe and effective medications are approved. Her insights into the rejection of Rimonabant by the FDA highlight how these reviews can save lives.
But it's not just about the science; Dr. Bainbridge also touches on the human side of research. She discusses how legalization impacts patient honesty with their doctors and the challenges of regulating products from dispensaries versus those used in clinical trials. If you’re curious about the behind-the-scenes efforts that go into developing cannabis medications, this episode is a must-listen. Dr. Bainbridge's passion for her work and her commitment to transparency in research offer a fascinating glimpse into this evolving field.